Navigation Links
West Clinic Continues Expansion Into Asian Market With Opening of Shanghai Cancer Center
Date:10/22/2007

Growing Cancer Care Pipeline Offers State-of-the-art Treatment

MEMPHIS, Tenn., Oct. 22 /PRNewswire-USNewswire/ -- West Clinic, a recognized leader in cancer care, announced today the opening of West Clinic International Shanghai. The 7000 square foot, state-of-the art facility is being opened in collaboration with Shanghai Kanglian Hospital and will provide 'western-style' comprehensive cancer care. Shanghai represents the second center opened by Memphis-based West Clinic International during the past year. West Clinic International Singapore opened in October, 2006.

Tennessee Governor, Phil Bredesen, and Commissioner of Economic and Community Development, Matt Kisber, were present at today's official opening. The event coincides with the Governor's 9-day China Trade Mission which included the opening of the Tennessee-China Development Center in Beijing on October 18, 2007.

"West Clinic and literally hundreds of health care companies have made Tennessee a center for innovation and improvement in the quality of care delivery around the world," said Governor Bredesen. "The expansion of ties between Tennessee and China in the area of health care is a primary focus of this trade mission."

"The Chinese government has been very open with us about starting a dialogue on the development of facilities like the one announced today," said Commissioner Kisber. "West Clinic's expertise in this area is extremely valuable."

Steven Tucker, MD, FACP will serve as Medical Director for West Clinic International Shanghai. Tucker will continue his current role as Medical Director for West Clinic International Singapore while assuming responsibility for the Shanghai center. Dr. Tucker also serves as President of The International Medical Travel Association and Medical Director for the Accelerated Community Oncology Research Network (ACORN) - Asia Division.

The facility will house full-service laboratory and state-of-the-art imaging technologies including digital x-ray, ultrasound, echocardiography and mammography. The center will offer comprehensive oncology services and treatments including contemporary chemotherapy, novel targeted therapies, biological therapies, immunotherapy, and anti-angiogenic therapy in addition to genetic and nutritional counseling, palliative care, and pain management.

Access to the latest research and clinical trials will be available to patients through West Clinic International Shanghai's collaboration with the Accelerated Community Oncology Research Network (ACORN). Until recently, access to such clinical trials has been difficult or often impossible for patients in China.

According to Tucker, "The positive response from patients and families in Asia has been overwhelming. West Clinic International is privileged to offer comprehensive cancer care to such a large and expanding community of people. We are striving to work closely with and integrate into this advancing medical community."

West Clinic International Shanghai at Shanghai Kanglian Hospital is located at No. 388 Hongbaoshi Road, Sixth Floor, Changning District, and Shanghai 200336. For additional information please call +86 21 6270 4900; Fax +86 21 6270 4942; email: info@westclinicshanghai.com; visit http://www.westclinicshanghai.com

Deborah D. Coble

Director, Corporate Communications

901-683-0055 x 1312(office)

901-831-1010 (cell)

dcoble@westclinic.com


'/>"/>
SOURCE West Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. How do patients benefit of clinical trials
3. Magnetic resonance angiography in clinical medicine
4. Clinical trials need to be more frank
5. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
6. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
7. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
8. Clinical Comparisons Between ADHD Drugs Are Less
9. Specialized Clinics For Manipurs AIDS Patients
10. Outsourcing clinical trials to India
11. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater Houston area ... will win a visit by a Houston Texans player, two tickets to a Texans ... years old can visit texanschecking.com/stars to nominate their favorite teacher with an essay of ...
(Date:8/16/2017)... Georgia (PRWEB) , ... August 16, 2017 , ... ... in Atlanta, opened their doors. They celebrate 30 years in business this year, ... create an up-to-date, inviting, tranquil space to serve their patients. , It ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced ... draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization ... out of a needle stick and more importantly, helps our staff members locate a ...
(Date:8/16/2017)... ... 2017 , ... A global leader in the treatment of clubfoot, CURE ... Indian states—bringing the country one step closer to eliminating clubfoot as a lifelong disability ... on track to enroll 10,000 children in the clubfoot treatment program in this year ...
(Date:8/16/2017)... ... ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has announced their ... a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their content will ... in 2018. Proceeds will be going to further health research. , Fusion Flix ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: